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Background: Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome associated with acute and
chronic liver diseases. It includes a number of neuropsychiatric disturbances including impaired motor activity and
coordination, intellectual and cognitive function.
Results: In the present study, we used a chronic rat HE model by ligation of the bile duct (BDL) for 4 weeks. These
rats showed increased plasma ammonia level, bile duct hyperplasia and impaired spatial learning memory and
motor coordination when tested with Rota-rod and Morris water maze tests, respectively. By immunohistochemistry,
the cerebral cortex showed swelling of astrocytes and microglia activation. To gain a better understanding of the
effect of HE on the brain, the dendritic arbors of layer V cortical pyramidal neurons and hippocampal CA1 pyramidal
neurons were revealed by an intracellular dye injection combined with a 3-dimensional reconstruction. Although
the dendritic arbors remained unaltered, the dendritic spine density on these neurons was significantly reduced. It
was suggested that the reduction of dendritic spines may be the underlying cause for increased motor evoked
potential threshold and prolonged central motor conduction time in clinical finding in cirrhosis.
Conclusions: We found that HE perturbs CNS functions by altering the dendritic morphology of cortical and
hippocampal pyramidal neurons, which may be the underlying cause for the motor and intellectual impairments
associated with HE patients.
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Hepatic encephalopathy is a common disease caused by
the liver failure. The consequential disorders of the liver
include the cirrhosis, hepatitis, urea cycle defect or lack of
blood circulation to the liver [1]. The exact cause of hepatic
encephalopathy is still unclear, but ammonia [the term
“ammonia” refers to total ammonia:gas (NH3) + ion (NH4
+)]
may be involved [2]. Ammonia is a metabolite which is
mostly produced within the gut during protein digestion
and deamination. It can diffuse into the capillaries of gut,
and thence transferred to the hepatocytes for urea cycle [3].
The liver maintains the concentration of ammonia in the
systemic circulation [4]. Hyperammonaemia develops if the
urea cycle cannot control the ammonia overload. Ammonia* Correspondence: chenjr@dragon.nchu.edu.tw; wtj@nutc.edu.tw
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stated.crosses the blood-brain barrier readily, and it enters the
brain from blood by diffusion rather than via a saturable
transport system. The brain uptake index for ammonia is
independent of arterial ammonia levels over a wide range
of concentrations. It is known that the brain has a highly
integrated system whose astrocytes are endowed with
glutamine synthetase that protect it against serum derived
toxicity. The ammonia is detoxified temporarily by its
incorporation into the non-toxic amino acid glutamine,
but continual hyperammonemic assault would induce
glutamine accumulation in the cytoplasm and mitochon-
dria. The glutamine in mitochondria is subsequently hydro-
lyzed leading to high levels of ammonia. This triggers
oxidative and nitrosative stress, the mitochondrial perme-
ability transition and mitochondrial injury, a sequence of
events that have been termed as the Trojan horse hypothesis
of HE [5,6].
HE has a lot of symptoms, and most of them are closely
related to the functions of the central nervous system.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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and a number of neuropsychiatric disturbances such as
somnolence, confusion, sleep-wake inversions, impairments
of sensory-motor integration, cognitive performance,
attention and memory, or even coma [2,7]. High ammonia
level is believed to be the cause for neuropsychiatric distur-
bances [2]. Brain imaging confirms that hyperammonemic
neonates and infants show cortical atrophy, ventricular
enlargement, demyelination or gray and white matter hypo-
densities [8-10]. Some structural alterations have been asso-
ciated with the deleterious effects of hyperammonemia.
Astrocytes which are metabolically hyperactive, appeared
to undergo histological changes in hyperammonemic brain
[11,12]. Some studies have reported that the inhibitory and
excitatory neurotransmission might be directly affected by
ammonia toxicity. The excitotoxicity induced by hyperam-
monemia would further trigger the production of nitric
oxide synthases (NOS), increase in oxidative stress such as
increased production of reactive oxygen and nitrogen oxide
species (ROS/RNOS). Thus, in HE model, there is evidence
of over-expression of nNOS in the cerebral cortex [13],
cerebellum [14,15] and striatum [16]. However, the effects
of ammonia on central neurons have remained elusive. In
view of this, we have used an intracellular dye injection
technique along with behavioral tests to investigate whether
the behavioral defects in bile duct ligation-induced HE
model might be correlated with the changes of dendritic
structures of cortical pyramidal neurons.
Methods
Animals
Thirty male Sprague-Dawley (SD) rats weighing 250-350 g
were used for the study. The rats were divided into three
groups. Of these, 20 of them were subjected to the
common bile duct ligation to induce liver fibrosis and
they were allowed to survive for 4 weeks. The surgery
of common bile duct ligation followed previous protocol
[17]. Briefly, the rats were operated under deep anaesthesia
with ketamine and xylazine (8 mg ketamine and 1 mg
xylazine/100 g body weight) and a double surgical ligation
was placed (2 silk knots proximal to bifurcation were tied
on common duct) and the common bile duct was sectioned
between both knots. The surgical rats were divided into
two groups. Firstly, half of the rats were fed with normal
diet for 4 weeks (BDL, n = 10). As in previous article [18],
feeding ammonium acetate could increase blood ammonia
level, so some BDL rats in our study were fed with diet
containing ammonium acetate (BDLHD, 10% w/w) for
last 2 weeks (n = 10) to exacerbate the liver dysfunction.
Ten rats served as sham-operated controls. Rats were
caged individually with water ad libitum in a temperature
(24 ± 1°C) and humidity-controlled room with 12-hour on,
12-hour off lighting schedule. All experimental procedures
were approved by the Animal Care and Use Committee ofthe National Chung-Hsing University under guidelines of
the National Science Council of Taiwan.
Behavioral tests
The protocols were modified from Jones and Roberts [19]
and Chen et al. [20] to evaluate the motor coordination
and spatial learning memory performance of the rats. All
rats were subjected to rotarod and Morris water maze
tasks before been scheduled for surgical operation and
sacrifice.
Rotarod test
The motor coordination of HE rats was assessed with an
accelerating rotarod apparatus (Ugo Basile, Comerio, Italy)
[19]. Rats were trained twice a day for two consecutive
days prior to testing. Training sessions consisted of
maintaining the rats on the rod for 3 min at the speed
(12 rpm). In the test, the rats were evaluated for 3 min in
the session, in which the rotation rate increases constantly
to reach 12 rpm and the direction of rotation was reversed
with each 12 seconds. The mean latency to fall off the
rotarod was recorded as the mean of three trials for
each rat.
Morris water maze task
Animal performance was recorded with a video camera
for subsequent analysis of the path and swimming speed.
The maze apparatus consisted of a circular pool 200 cm
in diameter and 60 cm deep. The pool was filled with water
at approximately 23°C to a height of 50 cm. A transparent
platform (diameter 15 cm) was placed at a constant
position 2-3 cm below the surface of the water. The
visual cues arrayed around the room were made available
for the rats to learn the location of the hidden platform.
The rats were tested for 3 consecutive days with two trials
per day. Rats were allowed to remain on the platform for
20 s if escaped within 180 s, or alternatively placed on the
platform and remained there for 20 s if failed to locate the
underwater platform within 180 s. A recovery period of 10
minutes was allowed between the two trials. The escape
times of the two trials conducted each day were recorded
and averaged.
Tissue preparation
At the end of the survival period the rats in each group
were divided into two subgroups. One (N = 5) is decapitated
and processed for ammonia level measuring of cerebral
cortex as described below. The other (N = 5) is sacrified
and processed for intracellular dye injection and immuno-
histochemical staining as described previously [21]. Briefly,
the rats were deeply anaesthetized and perfused with 2%
paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.3,
at room temperature for 30 min. Immediately following
the perfusion, the whole brain was carefully removed and
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national, St. Louis, MO) into 350-μm-thick coronal slices.
Half of the thick slices collected were processed by an
intracellular dye injection to reveal the dendritic arbor of
selective individual neurons. The remaining tissue slices
were postfixed in 4% paraformaldehyde in 0.1 M PB for 2
days. They were then cryoprotected and resectioned into
20-μm sections [21] for studying the cytoarchitecture as
described below.
Intracellular dye injection and subsequent
immunoconversion of the injected dye
The cerebral neurons whose cell nuclei emitting fluores-
cence with 10-7 M 4′, 6-diamidino-2-phenyl-indole (DAPI;
Sigma-Aldrich, St. Louis, MO) under the filter set were
visualized by an intracellular injection of Lucifer yellow
(LY, Sigma-Aldrich) which emitted a yellow fluorescence
[21,22]. For this purpose, the brain slice was placed in a
chamber on the stage of a fixed-stage fluorescence micro-
scope (Olympus BX51) and covered with 0.1 M PB. A
glass micropipette filled with 4% LY in water was steadily
positioned with a three-axial hydraulic micromanipulator
(Narishige, Tokyo, Japan) for dye injection. The intracellular
amplifier (Axoclamp–IIB) was used to generate injection
current. When the dye injection was completed, the brain
slice were rinsed with 0.1 M PB and postfixed in 4% para-
formaldehyde. The brain slices given dye injection were
then cryoprotected and sectioned into 60-μm-thick serial
sections for subsequent immunoconversion.
The sections derived from above were first incubated
with 1% H2O2 in PB for 30 min and then incubated in PBS
containing 2% Bovine Serum Albumin (Sigma-Aldrich)
and 1% Triton X-100. Sections were then treated with bio-
tinylated rabbit anti-LY (1:200; Molecular Probes, Eugene,
OR) in PBS for 18 hours at 4°C and then with standard
avidin-biotin HRP reagent (Vector, Burlingame, CA) for
1 hour at room temperature. They were then reacted with
0.05% 3-3′-diaminobenzidine tetrahydrochloride (DAB,
Sigma) and 0.01% H2O2 in 0.05 M Tris buffer. Reacted
sections were mounted on subbed slides, air-dried, and cov-
erslipped in Permount for 3-dimensional reconstruction.
Immunohistochemical procedures
Some brain sections were stained with Cresyl violet for
cell density and soma area evaluation of cortical pyramidal
neurons. To reveal microglia, astrocytes or nNOS + cells,
sections were reacted with goat antibodies to Iba1 (Abcam,
1:2000, Cambridge, UK), rabbit polyclonal antibodies to
glial fibrillary acidic protein (GFAP, 1:400, Merck Millipore,
Temecula, California) or monoclonal antibody to the nNOS
(1:1000, Santa Cruz Biotechnology, Santa Cruz, California),
respectively, for 18 h at 4°C. Biotinylated rabbit anti-goat
(1:200), goat anti-rabbit (1:200) and horse anti-mouse
(1:200) immunoglobulins were used as the secondaryantibodies, respectively. Subsequent DAB reaction process
followed that described previously [21].
Serum biochemical measurement
Blood samples (1.5 ml) were collected via the inferior vena
cava when sacrificing the animals (9:00 AM). The sample
was centrifuged (3000 × g, 15 min, 4°C) before measure-
ment. Levels of alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST) were assayed with an ADVIA
1800 analyzer (Siemens Medical Solutions Diagnostics Pte
Ltd., Swords, Ireland) with alanine aminotransferase (P/N
03036926, Bayer Siemens) and aspartate aminotransferase
(P/N 03039631, Bayer Siemens) reagents commissioned
by a clinical laboratory (UM Clinical Laboratory, Taichung,
Taiwan).
Ammonia colorimetric assay
The blood sample and homogenized cortex were collected
and centrifuged with spin filter (ab93349, Abcam) to
remove excessive proteins. After centrifugation, the assays
were performed according to the manufacturer’s specifica-
tions (K370-100, BioVision) using a Microplate Reader
(Infinite F50, Tecan Co., Mannedorf, Switzerland) to detect
the level of ammonium ion.
Data analysis
The cell density of microglia, nNOS + and pyramidal
neurons in primary sensorimotor cortex was randomly
counted twice in each section per 3402, 13902 and
502 μm2, respectively. Ten sections of each rat were ana-
lyzed. The soma area of layer V pyramidal neurons and as-
trocytes in primary sensorimotor cortex was reconstructed
using a Camera lucida drawing tube at 100× oil-objective
lens in two-dimensional plane. Fifty pyramidal neurons or
astrocytes of each rat were randomly chosen from section
to analyze their soma size. The astrocytes with a clear cell
border and all-around processes were chosen to draw their
outline of cell body. In astrocyte end-feet analysis, ten
astrocytes of each rat were analyzed. All terminal boutons
in the process end within a radius of 50 μm around an
astrocyte were counted. The demarcation between soma
and process was taken as the point where the convex
curvature of the soma became concave [21]. To study the
changes of dendritic arbor and length of layer III and layer
V pyramidal neurons, the complete dendritic arbors of 5
neurons in each rat were reconstructed 3-dimensionally
with Neurolucida (MicroBrightField, Williston, VT). To
determine the density of dendritic spines, 5 representative
CA1 and layer V pyramidal neurons each from each rat
from the respective treatment groups were randomly ana-
lyzed. Dendrites of the studied CA1 and layer V pyramidal
neurons were divided into proximal and distal seg-
ments of the apical and basal dendrites following the cri-
teria described before [20,21]. Briefly, for layer V pyramidal
Figure 1 Representative micrographs showing the liver lobules
in HE rat. Bar = 100 μm in A-C.
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as the segments 50–100 μm (around the first to second
branch), and 150–200 μm (around the last one or two
branches) from where they originate from the soma,
respectively. Proximal apical dendrites were the first or
second branch of the apical trunk and distal apical den-
drites were the terminal dendrites after the last branch
point in V pyramidal neurons. For hippocampal CA1 pyr-
amidal neurons, basal dendrites were defined as those in
the stratum oriens while apical dendrites were on the other
side of the cell body layer with the proximal segment in
the stratum radiatum and distal segment in the stratum
lacunosum-moleculare as the criteria described before [20].
Data was expressed as mean ± SE unless otherwise indicated.
Statistical significance was tested with one-way analysis of
variance (ANOVA) followed by the Newman-Keuls test to
find out any difference between treatment groups.
Results
The H&E stained inferior caudate lobe of the liver was
used to evaluate the pathological changes following the
bile duct ligation surgery (Figure 1). The hepatocytes form-
ing the hepatic cords were neatly arranged in the control
rat. After bile duct ligation (BDL) the hepatic cords were
noticeably decreased and bile duct expanded and appeared
hyperplasia (Figure 1B and C). In BDLHD rats the bile duct
proliferation was more drastic (Figure 1C).
Biochemical and behavioral changes of HE rats
To find out whether the BDL or BDL combining ammonia
acetate treatment (BDLHD) would have adverse effects on
the hepatic functions, we analyzed the ammonia level, AST
and ALT (Figure 2). The AST and ALT were 135 ± 8.1 U/L
and 68.6 ± 3.6 U/L in control rats; 607.8 ± 127.1 U/L and
182.5 ± 31.4 U/L in BDL rats; 785.6 ± 153.1 U/L and
194.7 ± 47.1 U/L in BDLHD rats, respectively. The ammo-
nia levels of serum and cerebral cortex in control rats were
51 ± 7.6 μmol/L and 0.22 ± 0.02 μmol/g; 229 ± 39.2 μmol/L
and 0.58 ± 0.1 μmol/g in BDL rats; 276.3 ± 43.7 μmol/L and
0.84 ± 0.15 μmol/g in BDLHD rats, respectively. Com-
promised hepatic functions were evident as manifested
by raised levels of AST and ALT and ammonia in BDL
and BDLHD rats.
To explore whether hyperammonemia would alter the
sensorimotor cortical function and spatial learning mem-
ory, we next assessed the sensory motor integration with
rotarod (Figure 3A). Both BDL and BDLHD rats main-
tained a short time in their motor performance, 41.5 ±
12.3% and 11.3 ± 6.1%, but the BDLHD group was poorer
in performance than BDL animals.
For hippocampus-related functions, we assessed the
spatial memory with the water maze task. The BDL and
BDLHD rats utilized longer duration, an increase by 2.6
and 4.6 folds, respectively, to locate the hidden platformthan the control rats (Figure 3B). This was accompanied by
a tripling of the swimming path (Figure 3C). The swimming
speed in BDL and BDLHD rats was decreased compared
with control rats but the reduction was not statistically
significant.
Morphological changes of cerebral cortex in HE rats
The sensorimotor cortex of BDL and BDLHD rats
remained six-layered in structure; there was no evidence
Figure 2 Biochemical values in HE rats. The AST (A), ALT (B) and ammonia levels of serum (C) and cerebral cortex (D) or HE rats were measured.
*, p < 0.05 between the experimental rats and sham control.
Figure 3 Behavioral performances in HE rats. The Rotarod (A) and Morris water maze (B, C and D) tests were analyzed in BDL and BDLHD
rats. These data was normalized to those obtained before HE induction. *, p < 0.05 between the marked and control rat; #, p < 0.05 between the
marked and BDL rats.
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nohistochemistry, the staining intensity of astrocytes in
BDL and BDLHD rats increased in comparison with that
in the control rats (Figure 4A-C). In the BDL and BDLHD
rats, the soma size of astrocytes was increased by about
55% and 65%, respectively, as compared with that of the
control rats (Figure 5A). There was no swollen end-feet
around the astrocytes in the control rats. After BDL
surgery, more thickened processes (* in Figure 4B-C) and
bouton-like terminals (end-feet, arrow in Figure 4B-C) were
observed at high magnification. The number of end-feet
around each astrocyte in BDL and BDLHD rats was 5.7 ±
0.82 and 6.2 ± 0.95, respectively. Iba1-immunoreactivated
microglia was counted and analyzed (Figure 4D-F). Based
on the external morphology, the Iba1+ glia cells could beFigure 4 Representative micrographs showing astrocytes and microg
(A-C) and right column was Iba1-immunoreactive microglia (D-F) in sham
magnification, thickened processes (*) and bouton-like terminals (arrow) we
antibodies labeled both inactive microglia (insert of D) and activated microdivided into inactivated (insert in Figure 4D) and activated
microglia (inserts in Figure 4E and F). The total number
of microglia was not increased significantly, but the acti-
vated microglia was respectively increased by 79 and 109%
in BDL and BDLHD rats (Figure 5B). In comparison with
the control rats, the density of nNOS + neurons was rela-
tively unchanged in both BDL and BDLHD rats (Figure 5C).
There was no noticeable change in the soma size (Figure 5D)
and cell density (5E) of major output pyramidal neurons
of sensorimotor cortex in layer III and layer V.
Alteration of dendritic structures on sensorimotor cortical
pyramidal neurons in HE rats
To investigate the morphological correlates of the effect
ammonia on sensorimotor integration in the brain, welia in HE rats. The left column was GFAP-immunoreactive astrocytes
control (A and D), BDL (B and E) and BDLHD (C and F). At a high
re easily identified in BDL and BDLHD rats. The polyclonal Iba1
glia (inserts of E and F). Bar = 300 μm in A-C, 20 μm for inserts.
Figure 5 The cytoarchitecture of sensorimotor cortex in HE rats. The soma size of astrocytes and layer III / V pyramidal neurons
(A and B) and density of nNOS+ neurons (C) and microglia (D) were measured in sensorimotor cortex. *, p < 0.05 between the mark and
control rats.
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idal neurons, of the sensorimotor cortex. Hyperammone-
mia did not appear to affect the apparent shape of the
dendritic arbor (Figure 6A-C), dendrogram (details not
shown), dendritic length or number of terminal ends
(Figure 7A and B). We then scrutinized the dendritic
spines on these neurons (Figure 8A). The spine density
on proximal and distal segments of the apical and basal
dendrites of layer V pyramidal neurons was significantly
reduced by 23-40% and 23-46% in BDL and BDLHD rats,
respectively, (Figure 8C).
For the spatial learning memory functions, we focused
on the hippocampal CA1 pyramidal neurons to explore
possible morphological changes induced by hyperammone-
mia. As in the layer V pyramidal neurons of sensorimotor
cortex, hyperammonemia also had no effect on the den-
dritic arbor of hippocampal CA1 pyramidal neurons
(Figure 6D-F, 7C and 7D). The spine density on the basal
dendrite and proximal and distal segments of the apical
dendrites of CA1 pyramidal neurons was significantly
reduced by 27-47% and 24-40% in BDL and BDLHD
rats, respectively, (Figure 8B and D).
Discussion
This study has succeeded in establishing a HE model in
rats through ligation of the common bile duct followed
by feeding the rats with diet containing ammonium acetate
which results in hyperammonemia. More importantly,
we have shown that the induced hyperammonemia
compromised the sensorimotor integration and spatiallearning memory. Moreover, at the cellular level, the
astrocytes increased in cell size by 55-65%. The total micro-
glial number was not significantly increased but the fre-
quency of activated microglia was increased by 79-109%.
Very interestingly, the dendritic arbors of layer V and CA1
pyramidal neurons in the primary sensorimotor cortex and
hippocampus were not affected. A striking change, how-
ever, occurred at the dendritic spines whose density was
significantly decreased in HE rats. These changes were
consistently observed on all segments of the basal and
apical dendrites. On the other hand, changes in dendritic
structures were revealed in sparse-fur mice, which are
deficient in ornithine transcarbamylase. In this congenital
metabolic deficiency, the layer V pyramidal neurons in
frontoparietal cortex displayed retraction of basal dendritic
arbor and decrease in spine density of dendritic terminal
[23]. The reduced complexity in basal dendritic arbor in
spf/Y mice may have the following explanations. Firstly,
ornithine transcarbamylase deficiency might affect the den-
dritic maturation of cortical pyramidal neurons. In general,
dendrite arbors on central neurons reach their normal
mature size during 3rd~4th postnatal weeks, and the
synaptic transmission is pivotal to the proper development
of mature central neuronal architecture [24,25]. It is spec-
ulated that in spf/Y mice, the dendritic arbors of cortical
pyramidal neurons might not reach their full maturation.
Secondly, in our HE model, the duration of ammonia
influence is less than one month. This may be another
possible explanation for the discrepancy in results between
that of the above authors and ours. In addition, the above
Figure 6 Representative 3-dimensionally reconstructed pyramidal neurons. The layer V (A – C) pyramidal neurons of the primary
sensorimotor cortex and hippocampal CA1 (D – F) pyramidal neurons were reconstructed with Neurolucida®. The apical dendritic trunk was in
red while the filled blue circle represents cell body. Branches of each basal dendritic trunk were displayed with the same color. Roman numerals
and horizontal bars on the left of each drawing mark the cortical layers. Bar = 200 μm in A-C and 100 μm in D-F.
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lar dendritic tree of layer V pyramidal cells in frontoparietal
cortex. The Golgi labels neurons capriciously and often
results in overlapping and incomplete dendritic arbors
in sections to impede analysis [26]. In the present study,
we employed intracellular dye injection [20-22,27,28] to
reveal the dendritic arbors of the studied pyramidal neu-
rons. This allowed us to study specifically identified layer V
and CA1 pyramidal neurons. Neurons, well-spaced apart,
could be individually filled with no time constraint. With
proper orientation, we were able to preserve most of thedendritic arbors for instance of the relatively large layer V
and CA1 pyramidal neurons close to completeness in a
350 μm-thick brain slice.
Unlike dendritic arbors, dendritic spines are highly motile
structures that have been shown to be swiftly and dy-
namically modulated by many factors such as changes
in environment [29], gonadal hormones [27,28,30], physical
compression and decompression [21,22], fatigue [20],
insults such as axonal injury [31], deafferentation [32], and
aging [33]. Here, we have shown that hyperammone-
mia significantly decreased the spine density in layer V
Figure 7 The dendritic arbor of pyramidal neurons was analyzed in HE rats. The dendritic arbors of layer V (A and B) pyramidal neurons of
the primary sensorimotor cortex and hippocampal CA1 (C and D) pyramidal neurons were analyzed.
Figure 8 The spine loss of pyramidal neurons in HE rats. The spine density on layer V (A) pyramidal neurons of the primary sensorimotor
cortex and hippocampal CA1 (B) pyramidal neurons was analyzed. Representative micrographs of basal segment and distal apical segment of
dendrite were illustrated in A and B. Spine density was measured and analyzed in C and D. *, p < 0.05 between the mark and control rats.
Bar = 10 μm for all photograph.
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pal CA1 pyramidal neurons (24-47%). The dendritic spines
of layer V pyramidal neurons in frontoparietal cortex
displayed more than 60% loss in sparse-fur mice [23]. In
the clinic, threshold to evoke peripheral motor responses
to transcranial magnetic stimulation of the primary cortical
motor area was increased in the presence of hepatic en-
cephalopathy, and this might be attributed to an ammonia
induced loss of glutamatergic excitatory synaptic inputs
to cortical pyramidal neurons [34,35]. Because there was
no significant change in cell density, soma size of layer V
pyramidal neurons as well as there was no evidence of
neuronal death in the sensorimotor cortex, it is suggested
that the significant reduction in spine density of cortical
pyramidal neurons had contributed to the behavioral
dysfunction as observed in the present HE rats.
As far as can be ascertained, there is no defined mechan-
ism to explain the spine loss of cortical pyramidal neurons
in HE model rats. It is speculated that this may be multi-
factorial. Thus, the possibility of involvement of neuroglia
activation or oxidative stress is considered. Microglia was
robustly activated and underwent proliferation in hyper-
ammonemia [36,37]. The microglia proliferation and as-
trocytes swelling might further increase the surrounding
pressure which could decrease the dendritic spines of
cortical pyramidal neurons [21]. Recent studies have shown
that interaction of microglia with synapses contributes
to synaptic remodeling during development [38] and adult
[39]. The oxidative stress might be another factor causing
decrease in the dendritic spines of cortical pyramidal
neurons. There is evidence that hyperammonemia could
enhance the production of ROS/RNOS in astrocytes [36,40].
Excessive ammonia in synaptic cleft may be mediated
by an excitotoxic mechanism, oxidative stress and nitric
oxide (NO) production in cortical neurons [41]. These
oxidative stresses further inhibit the synaptic transmission
and promote the synaptic remodeling. Our ongoing stud-
ies also found that high oxidative stress, induced by
D-galactose, significantly decreases the spine density of
layer V sensorimotor cortical neurons and hippocampal
CA1 pyramidal neurons, and, remarkably, exogenous anti-
oxidant can fully restore it (unpublished data).
In HE rats, the astrocytes showed enhanced GFAP im-
munoreactivity, increase in soma size and swollen end-feet.
Similar results of astrocyte swelling were observed in vivo
[37] and in vitro [42,43] in rats. Astrocytic reaction is a
hallmark feature of brain edema and its complications
(intracranial hypertension, brain herniation) in HE patients
[44]. Astrocyte swelling may be caused by over-expression
of aquaporin-4 protein [42,45], or an auto-amplificatory
loop between ROS/RNOS formation and astrocyte swelling
[36,40]. Hyperammonemia is also frequently complicated
by systemic inflammation including increasing systemic
and cerebral levels of vascular endothelial growth factor(VEGF), Tumor Necrosis Factor (TNF)-alpha and the in-
terleukins (IL)-1beta and IL-6 [46]. The VEGF may stimu-
late liver regeneration but it can also be pro-inflammatory,
activating endothelial cells and increasing permeability,
actions mediated through Src kinase signaling [47]. These
proinflammatory cytokines progress in parallel with the se-
verity of astrocyte swelling [46]. The alterations in blood-
brain barrier remain unclear although some studies have
shown disruption of tight junction proteins indicative of
involvement of blood-brain barrier in cellular swelling
[48,49]. Hypertrophy of end-feet of astrocytes was evident
after BDL surgery, but there was no noticeable difference
between the BDL and BDLHD rats. More studies are
desirable to confirm whether the enlarged end-feet may
be correlated with the blood-brain barrier damage in BDL
rat model. A feature worthy of note is that hyperammone-
mia promotes the astrocyte swelling but has no affect on
soma area of layer III and Layer V pyramidal neurons in
sensorimotor cortex. In vitro culture study showed that
NH4Cl could promote the swelling of culture astrocytes
and microglia in a glutamine-synthesis dependent way but
has no effect on cell volume of cultured neurons [36].
Conclusion
Hyperammonemia, in addition to affecting peripheral or-
gans, also alters the structure of astrocytes and central
neurons. It enhances the astrocyte swelling and microglia
activation; moreover, it significantly decreases the spine
density of layer V sensorimotor cortical neurons and
hippocampal CA1 pyramidal neurons, which may be the
underlying cause for the motor and intellectual impair-
ments associated with HE patients.
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